Daniel D. Shoemaker

2016

In 2016, Daniel D. Shoemaker earned a total compensation of $713.2K as Chief Scientific Officer at Fate Therapeutics, a 25% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$77,350
Option Awards$295,800
Salary$340,000
Total$713,150

Shoemaker received $340K in salary, accounting for 48% of the total pay in 2016.

Shoemaker also received $77.4K in non-equity incentive plan and $295.8K in option awards.

Rankings

In 2016, Daniel D. Shoemaker's compensation ranked 9,798th out of 14,075 executives tracked by ExecPay. In other words, Shoemaker earned more than 30.4% of executives.

ClassificationRankingPercentile
All
9,798
out of 14,075
30th
Division
Manufacturing
3,787
out of 5,489
31st
Major group
Chemicals And Allied Products
1,321
out of 1,895
30th
Industry group
Drugs
1,050
out of 1,538
32nd
Industry
Biological Products, Except Diagnostic Substances
185
out of 279
34th
Source: SEC filing on March 22, 2017.

Shoemaker's colleagues

We found two more compensation records of executives who worked with Daniel D. Shoemaker at Fate Therapeutics in 2016.

2016

J Wolchko

Fate Therapeutics

Chief Executive Officer

2016

Stewart Abbot

Fate Therapeutics

Chief Development Officer

News

You may also like